Why does the Bonn Risk Index discriminate between calcium oxalate stone formers and healthy controls?
- PMID: 16407047
- DOI: 10.1016/S0022-5347(05)00145-X
Why does the Bonn Risk Index discriminate between calcium oxalate stone formers and healthy controls?
Abstract
Purpose: The BRI has been shown to discriminate between calcium oxalate stone formers and controls. BRI is the ratio of the concentration of ionized calcium and the amount of oxalate that must be added to 200 ml urine to initiate crystallization. Higher BRI values are predictive of being a stone former and a value of 1.0 has been found to be the cutoff value to distinguish stone formers and controls. It is not easy to present a consistent argument based on the thermodynamics of calcium oxalate crystallization to account for the success of this index. For instance, why should 2 samples sharing the same BRI but with different ionized calcium and oxalate values have the same likelihood of being obtained from a stone former?
Materials and methods: Using data on 195 samples the distribution and interrelationships of measured variables were examined. They were used to calculate illustrative data with which it was possible to examine the effects of varying the parameters and their relationships.
Results: Data simulations identified 3 necessary and sufficient conditions that must be met for BRI to be an effective discriminator between stone former and nonstone former urine samples.
Conclusions: The success of BRI can be explained as the natural outcome of there being significantly different distributions (stone formers vs nonstone formers) of the concentration of ionized calcium and the formation product minus activity product difference as well as the correlation between these 2 variables.
Similar articles
-
Determination of the calcium oxalate crystallization risk from urine samples: the BONN Risk Index in comparison to other risk formulas.J Urol. 2004 Jul;172(1):355-9. doi: 10.1097/01.ju.0000123822.20291.4d. J Urol. 2004. PMID: 15201810
-
Can the Bonn Risk Index be replaced by a simple measurement of the urinary concentration of free calcium ions?J Urol. 2005 Jun;173(6):2175-7. doi: 10.1097/01.ju.0000158128.21188.ff. J Urol. 2005. PMID: 15879882
-
[Monitoring of the treatment of calcium-oxalate stone formers with the Bonn-Risk-Index].Urologe A. 2003 Feb;42(2):243-9. doi: 10.1007/s00120-002-0246-7. Epub 2003 Jan 11. Urologe A. 2003. PMID: 12607094 German.
-
Methods for the study of calcium oxalate crystallisation and their application to urolithiasis research.Scanning Microsc. 1992 Sep;6(3):685-704; discussion 704-5. Scanning Microsc. 1992. PMID: 1439665 Review.
-
The role of Randall's plaques in the pathogenesis of calcium stones.J Urol. 2007 Jan;177(1):31-8. doi: 10.1016/j.juro.2006.08.088. J Urol. 2007. PMID: 17161996 Review.
Cited by
-
Temporary risk identification in urolithiasis.Urol Res. 2009 Dec;37(6):377-80. doi: 10.1007/s00240-009-0225-1. Epub 2009 Oct 15. Urol Res. 2009. PMID: 19830414
-
Correlation of Osteoporosis and Calcium Urolithiasis in Adult Population.Med Arch. 2016 Feb;70(1):66-8. doi: 10.5455/medarh.2016.70.66-68. Epub 2016 Jan 31. Med Arch. 2016. PMID: 26980936 Free PMC article.
-
A new approach to the diagnosis of children's urolithiasis based on the Bonn Risk Index.Pediatr Nephrol. 2008 Jul;23(7):1123-8. doi: 10.1007/s00467-008-0786-1. Epub 2008 Mar 12. Pediatr Nephrol. 2008. PMID: 18335253
-
Increased dietary long-chain polyunsaturated fatty acids alter serum fatty acid concentrations and lower risk of urine stone formation in cats.PLoS One. 2017 Oct 26;12(10):e0187133. doi: 10.1371/journal.pone.0187133. eCollection 2017. PLoS One. 2017. PMID: 29073223 Free PMC article.
-
Urolithiasis--an interdisciplinary diagnostic, therapeutic and secondary preventive challenge.Dtsch Arztebl Int. 2015 Feb 6;112(6):83-91. doi: 10.3238/arztebl.2015.0083. Dtsch Arztebl Int. 2015. PMID: 25721435 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous